Targeting bacterial endotoxin: Two sides of a coin

Annals of the New York Academy of Sciences

Volumn 1096, Issue , 2007, Pages 1-17

  Bosshart, Herbert ^a   Heinzelmann, Michael ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cytokines; Gram negative bacteria; Infection; Lipopolysaccharide; Peripheral blood monocytes; Sepsis

Indexed keywords

ARGININE; CD14 ANTIGEN; ENDOTOXIN; GLYCOSYLPHOSPHATIDYLINOSITOL; HISTIDINE; LIPID; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE BINDING PROTEIN; POLYSACCHARIDE SULFATE; TOLL LIKE RECEPTOR 4; CYTOKINE; PEPTIDE; TLR4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; CELL ACTIVATION; CELL DIFFERENTIATION; CELL WALL; CHEMICAL STRUCTURE; CONFERENCE PAPER; DEATH; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MONOCYTE; MORTALITY; MULTIPLE ORGAN FAILURE; SEPSIS; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; BIOSYNTHESIS; CHEMICAL MODEL; CHEMISTRY; INFECTION; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; REVIEW;

BACTERIA (MICROORGANISMS); MAMMALIA; NEGIBACTERIA;

AMINO ACID SEQUENCE; ANTIGENS, CD14; CYTOKINES; ENDOTOXINS; GRAM-NEGATIVE BACTERIA; HUMANS; INFECTION; LIPIDS; LIPOPOLYSACCHARIDES; MODELS, CHEMICAL; MOLECULAR SEQUENCE DATA; MONOCYTES; PEPTIDES; SEPSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 34247249926     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1397.064     Document Type: Conference Paper

References (51)

1. XU, J. & J.I. GORDON. 2003. Inaugural article: honor thy symbionts. Proc. Natl. Acad. Sci. USA 100: 10452-10459.
2. TAKEDA, K. & S. AKIRA. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
3. O'NEILL, L.A. 2004. After the toll rush. Science 303: 1481-1482.
4. HASAN, U., C. CHAFFOIS, C. GAILLARD, et al. 2005. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol. 174: 2942-2950.
5. ZHANG, D., G. ZHANG, M.S. HAYDEN, et al. 2004. A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522-1526.
6. BRUN-BUISSON, C., F. DOYON & J. CARLET. 1996. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am. J. Respir. Crit. Care Med. 154: 617-624.
7. MYC, A., J. BUCK, J. GONIN, et al. 1997. The level of lipopolysaccharide-binding protein is significantly increased in plasma in patients with the systemic inflammatory response syndrome. Clin. Diagn. Lab. Immunol. 4: 113-136.
8. JIANG, Q., S. AKASHI, K. MIYAKE, et al. 2000. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J. Immunol. 165: 3541-3544.
9. PUGIN, J., S. STERN-VOEFFRAY, B. DAUBEUF, et al. 2004. Soluble MD-2 activity in plasma from patients with severe sepsis and septic shock. Blood 104: 4071-4079.
10. MEDZHITOV, R., P. PRESTON-HURLBURT & C.A. JANEWAY JR. 1997. A human homologue of the Drosophila toll protein signals activation of adaptive immunity. Nature 388: 394-397.
11. ROCK, F.L., G. HARDIMAN, J.C. TIMANS, et al. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95: 588-593.
12. LORD, K.A., B. HOFFMAN-LIEBERMANN & D.A. LIEBERMANN. 1990. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL6. Oncogene 5: 1095-1097.
13. MARTIN, M.U. & H. WESCHE. 2002. Summary and comparison of the signaling mechanisms of the toll/interleukin-1 receptor family. Biochim. Biophys. Acta 1592: 265-280.
14. SAITOH, M., H. NISHITOH, M. FUJII M., et al. 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 17: 2596-2606.
15. MATSUZAWA, A., K. SAEGUSA, T. NOGUCHI, et al. 2005. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6: 587-592.
16. PARK, H.S., H.Y. JUNG, E.Y. PARK, et al. 2004. Direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J. Immunol. 173: 3589-3593.
17. SHINOBU, N., T. IWAMURA, M. YONEYAMA, et al. 2002. Involvement of TIRAP/MAL in signaling for the activation of interferon regulatory factor 3 by lipopolysaccharide. FEBS Lett. 517: 251-256.
18. HSU, L.C., J.M. PARK, K. ZHANG, et al. 2004. The protein kinase PKR is required for macrophage apoptosis after activation of toll-like receptor 4. Nature 428: 341-345.
19. O'NEILL, L.A., K.A. FITZGERALD & A.G. BOWIE. 2003. The toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24: 286-290.
20. MOYNAGH, P.N. 2005. TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway. Trends Immunol. 26: 469-476.
21. INGALLS, R.R., B.G. MONKS, R. SAVEDRA JR, et al. 1998. CD11/CD18 and CD14 share a common lipid A signaling pathway. J. Immunol. 161: 5413-5420.
22. HAMPTON, R.Y., D.T. GOLENBOCK, M. PENMAN, et al. 1991. Recognition and plasma clearance of endotoxin by scavenger receptors. Nature 352: 342-344.
23. GERTH, A., J. GROSCHE, K. NIEBER, et al. 2005. Intracellular LPS inhibits the activity of potassium channels and fails to activate NFkappaB in human macrophages. J. Cell. Physiol. 202: 442-452.
24. PERERA, P.Y., T.N. MAYADAS, O. TAKEUCHI, et al. 2001. CD11b/CD18 acts in concert with CD14 and toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J. Immunol. 166: 574-581.
25. PHILPOTT, D.J. & S.E. GIRARDIN. 2004. The role of toll-like receptors and Nod proteins in bacterial infection. Mol. Immunol. 41: 1099-1108.
26. FRITZ, J.H., S.E. GIRARDIN, C. FITTING, et al. 2005. Synergistic stimulation of human monocytes and dendritic cells by toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 35: 2459-2470.
27. WATSON, R.W., O.D. ROTSTEIN, J. PARODO, et al. 1998. The IL-1 beta-converting enzyme (caspase-1) inhibits apoptosis of inflammatory neutrophils through activation of IL-1 beta. J. Immunol. 161: 957-962.
28. POWER, C.P., J.H. WANG, B. MANNING, et al. 2004. Bacterial lipoprotein delays apoptosis in human neutrophils through inhibition of caspase-3 activity: regulatory roles for CD14 and TLR-2. J. Immunol. 173: 5229-5237.
29. KOLLEF, M.H. & D.P. SCHUSTER. 1995. The acute respiratory distress syndrome. N. Engl. J. Med. 332: 27-37.
30. HOTCHKISS, R.S. & I.E. KARL. 2003. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 348: 138-150.
31. HEZI-YAMIT, A., P.W. WONG, N. BIEN-LY, et al. 2005. Synergistic induction of tissue factor by coagulation factor Xa and TNF: evidence for involvement of negative regulatory signaling cascades. Proc. Natl. Acad. Sci. USA 102: 12077-12082.
32. ESMON, C.T. 2004. The impact of the inflammatory response on coagulation. Thromb. Res. 114: 321-327.
33. TEDDER, T.F., D.A. STEEBER, A. CHEN, et al. 1995. The selectins: vascular adhesion molecules. FASEB J. 9: 866-873.
34. COHEN, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
35. BOSSHART, H. & M. HEINZELMANN. 2002. Arginine-rich cationic polypeptides amplify lipopolysaccharide-induced monocyte activation. Infect. Immun. 70: 6904-6910.
36. MARIKOVSKY, Y., P. RESNITZKY & N. REICHMAN. 1978. Surface charge characteristics of peripheral blood lymphocytes in chronic lymphatic leukemia and malignant lymphoma. J. Natl. Cancer Inst. 60: 741-748.
37. MOIR, R.D. & G.H. DIXON. 1988. Characterization of a protamine gene from the chum salmon (Oncorhynchus keta). J. Mol. Evol. 27: 8-16.
38. KASTRUP, J.S., V. LINDE, A.K. PEDERSEN, et al. 2001. Two mutants of human heparin binding protein (CAP37): toward the understanding of the nature of lipid A/LPS and BPTI binding. Proteins 42: 442-451.
39. BOSSHART, H. & M. HEINZELMANN. 2004. Human neutrophil-derived CAP37 inhibits lipopolysaccharide-induced activation in murine peritoneal macrophages. Immunol. Lett. 94: 175-182.
40. HEINZELMANN, M., M.A. MERCER-JONES, H. FLODGAARD, et al. 1998. Heparin-binding protein (CAP37) is internalized in monocytes and increases LPS-induced monocyte activation. J. Immunol. 160: 5530-5536.
41. HEINZELMANN, M., M. MILLER, A. PLATZA, et al. 1999. Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes. Ann. Surg. 229: 542-550.
42. HEINZELMANN, M. & H. BOSSHART. 2005. Heparin binds to lipopolysaccharide (LPS)-binding protein, facilitates the transfer of LPS to CD14, and enhances LPS-induced activation of peripheral blood monocytes. J. Immunol. 174: 2280-2287.
43. CONRAD, H.E. 1998. Heparin-Binding Proteins. Academic Press. San Diego, CA.
44. HERBERT, J.M., M. PETITOU, J.C. LORMEAU, et al. 1997. SR 90107A (Org 31540): a novel anti-factor Xa antithrombotic agent. Cardiovasc. Drug Rev. 15: 1-26.
45. PETITOU, M., J.P. HERAULT, A. BERNAT, et al. 1999. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 398: 417-422.
46. HEINZELMANN, M. & H. BOSSHART. 2004. Fondaparinux sodium lacks immunomodulatory effects of heparin. Am. J. Surg. 187: 111-113.
47. BOSSHART, H. & M. HEINZELMANN. 2003. Endotoxin-neutralizing effects of histidine-rich peptides. FEBS Lett. 553: 135-140.
48. SUGIYAMA, K. 1993. Anti-lipopolysaccharide activity of histatins, peptides from human saliva. Experientia 49: 1095-1097.
49. MAHATO, R.I. 2005. Water insoluble and soluble lipids for gene delivery. Adv. Drug Deliv. Rev. 57: 699-712.
50. SIMBERG, D., S. WEISMAN, Y. TALMON, et al. 2003. The role of organ vascularization and lipoplex-serum initial contact in intravenous murine lipofection. J. Biol. Chem. 278: 39858-39865.
51. DUFFELS, A., L.G. GREEN, S.V. LEY, et al. 2000. Synthesis of high-mannose type neoglycolipids: active targeting of liposomes to macrophages in gene therapy. Chemistry 6: 1416-1430.